文献速递乳腺MR

术前诊断同侧和对侧乳腺癌:扩散加权MRI的作用

Preoperative Diagnosis of Ipsilateral and Contralateral Breast Cancer: Role of Diffusion-weighted MRI.
PubMed 文献 · Radiology · 2025-01-01

本回顾性研究评估了表观扩散系数(ADC)阈值在术前MRI检出乳腺癌患者额外病灶中的价值。在219例患者292个额外病灶中,最佳ADC阈值为1.0×10⁻³ mm²/秒,与单独动态对比增强MRI相比,特异度从28.7%升至73.1%(P<.001),敏感度从99.2%降至89.6%(P<.001)。验证队列(104例患者133个病灶)中,应用该阈值同样提高特异度(从21.2%至68.2%,P<.001)但降低敏感度(从97.9%至83.3%,P=.01)。

要点

  • 术前MRI额外病灶评估中,ADC阈值1.0×10⁻³ mm²/秒可提高特异度但降低敏感度。
  • 同侧病灶应用ADC阈值后敏感度未显著下降(97.1%至85.3%,P=.052)。
  • 对侧病灶应用ADC阈值后敏感度下降更明显(100%至78.6%,P<.001)。

核心结论

  • 基于DWI的ADC阈值可改善术前MRI对乳腺癌患者额外病灶的诊断效能,提高特异度但降低敏感度。

研究设计与样本

  • 回顾性研究,开发队列219例患者292个额外病灶(BI-RADS 3类或更高),验证队列104例患者133个额外病灶,由两名乳腺放射科医生独立评估强化病灶并测量ADC值。

诊断标准与关键数值

  • 最佳ADC阈值为1.0×10⁻³ mm²/秒(据约登指数确定);开发队列中相比单独DCE-MRI,特异度从28.7%升至73.1%(P<.001),敏感度从99.2%降至89.6%(P<.001);验证队列中特异度从21.2%升至68.2%(P<.001),敏感度从97.9%降至83.3%(P=.01);同侧病灶特异度从8.7%升至65.2%(P<.001),敏感度从97.1%降至85.3%(P=.052);对侧病灶特异度从35.9%升至71.8%(P<.001),敏感度从100%降至78.6%(P<.001);预设ADC值1.53×10⁻³ mm²/秒和1.3×10⁻³ mm²/秒获得更高敏感度但特异度改善较小。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The interpretation of the multiparametric MRI, which combines dynamic contrast-enhanced (DCE) MRI with diffusion-weighted imaging (DWI), has the potential to increase MRI diagnostic accuracy. Purpose To investigate and validate the potential of DWI with an apparent diffusion coefficient (ADC) cutoff in evaluating additional lesions detected at preoperative MRI in patients with breast cancer. Materials and Methods In this retrospective review, data from patients with additional lesions (Breast Imaging Reporting and Data System [BI-RADS] category 3 or higher) who underwent MRI between June 2019 and June 2021 were evaluated. Two breast radiologists independently evaluated additional enhanced lesions and measured the ADC values. The optimal ADC cutoff for downgrading lesions was determined according to the Youden index and was applied to a separate validation cohort. The efficacy of prespecified ADC values (1.53 × 10-3 mm2/sec and 1.3 × 10-3 mm2/sec) was investigated. Diagnostic performance was evaluated and compared using generalized estimating equations. Results Data from 219 patients (mean age, 50.8 years ± 10.2 [SD]) with 292 additional lesions were evaluated. The optimal ADC cutoff was 1.0 × 10-3 mm2/sec, which, compared with that for DCE MRI alone, increased specificity (from 28.7% to 73.1%; P < .001) but decreased sensitivity (from 99.2% to 89.6%; P < .001) of MRI. In the validation cohort (104 patients, 133 additional lesions), 48 of 133 (36.1%) lesions were diagnosed as cancer, and applying the ADC cutoff derived from the development cohort increased specificity (from 21.2% to 68.2%; P < .001) but decreased sensitivity (from 97.9% to 83.3%; P = .01). For ipsilateral lesions, specificity increased (from 8.7% to 65.2%; P < .001), but the sensitivity did not decrease significantly (from 97.1% to 85.3%; P = .052). For contralateral lesions, similar performance improvements were observed for specificity (from 35.9% to 71.8%; P < .001), but a greater decrease in sensitivity was observed (from 100% to 78.6%; P < .001). Application of the prespecified ADC cutoffs achieved higher sensitivity values but smaller improvements in specificity. Conclusion The ADC cutoff based on MRI with DWI improved the performance of preoperative MRI in diagnosing additional lesions in patients with breast cancer. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Honda and Iima in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kim HJ, Partridge SC, Lee J, et al. Preoperative Diagnosis of Ipsilateral and Contralateral Breast Cancer: Role of Diffusion-weighted MRI. Radiology. 2025. PMID: 40492914. doi:10.1148/radiol.242423

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。